BR0104358A - Formulações de taxana tendo solubilidade aperfeiçoada - Google Patents

Formulações de taxana tendo solubilidade aperfeiçoada

Info

Publication number
BR0104358A
BR0104358A BR0104358-7A BR0104358A BR0104358A BR 0104358 A BR0104358 A BR 0104358A BR 0104358 A BR0104358 A BR 0104358A BR 0104358 A BR0104358 A BR 0104358A
Authority
BR
Brazil
Prior art keywords
improved solubility
formulations
taxane
taxane formulations
clitaxel
Prior art date
Application number
BR0104358-7A
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of BR0104358A publication Critical patent/BR0104358A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: "FORMULAçõES DE TAXANA TENDO SOLUBILIDADE APERFEIçOADA". A presente invenção refere-se a várias formulações de taxanas tendo solubilidade aperfeiçoada se comparada com clitaxel, particularmente formulações de tais derivados de taxana para administração oral ou parenteral a um paciente.
BR0104358-7A 2000-02-02 2001-02-02 Formulações de taxana tendo solubilidade aperfeiçoada BR0104358A (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US17967400P 2000-02-02 2000-02-02
US17967000P 2000-02-02 2000-02-02
US17978200P 2000-02-02 2000-02-02
US17966900P 2000-02-02 2000-02-02
US17967200P 2000-02-02 2000-02-02
US17967100P 2000-02-02 2000-02-02
US17979300P 2000-02-02 2000-02-02
US17968400P 2000-02-02 2000-02-02
PCT/US2001/003624 WO2001057013A1 (en) 2000-02-02 2001-02-02 Taxane formulations having improved solubility

Publications (1)

Publication Number Publication Date
BR0104358A true BR0104358A (pt) 2002-01-02

Family

ID=27575082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0104358-7A BR0104358A (pt) 2000-02-02 2001-02-02 Formulações de taxana tendo solubilidade aperfeiçoada

Country Status (9)

Country Link
EP (1) EP1175414A1 (pt)
KR (1) KR20010111580A (pt)
AU (1) AU3481001A (pt)
BR (1) BR0104358A (pt)
HU (1) HUP0200995A3 (pt)
IL (1) IL145635A0 (pt)
NO (1) NO20014752L (pt)
NZ (1) NZ514073A (pt)
WO (1) WO2001057013A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
KR20010112395A (ko) 2000-02-02 2001-12-20 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서의 ｃ７ 카르보네이트 치환된 탁산
BR0104350A (pt) 2000-02-02 2002-01-02 Univ Florida State Res Found Taxanos de c10 acetato heterossubstituìdo como agentes antitumor
EP1200424B1 (en) 2000-02-02 2008-11-05 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
US6596737B2 (en) 2000-02-02 2003-07-22 Fsu Research Foundation, Inc. C10 carbamoyloxy substituted taxanes
PL350028A1 (en) 2000-02-02 2002-10-21 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
CA2354478A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes
CN100522955C (zh) 2002-08-02 2009-08-05 伊缪诺金公司 含有新型强效紫杉烷的细胞毒性剂及其治疗用途
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
PE20050693A1 (es) 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
JP2007527432A (ja) 2004-03-05 2007-09-27 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ７ラクチルオキシ置換タキサン
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
US5622986A (en) * 1993-10-20 1997-04-22 Enzon, Inc. 2'-and/or 7-substituted taxanes
AU4133096A (en) * 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5801191A (en) * 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
CN1097044C (zh) * 1996-07-15 2002-12-25 亚库尔特株式会社总社 紫杉烷衍生物以及含有该衍生物的药物
JPH1192468A (ja) * 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
AU758418B2 (en) * 1997-12-19 2003-03-20 Kabushiki Kaisha Yakult Honsha Taxane derivatives
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
NZ514073A (en) 2004-02-27
WO2001057013A1 (en) 2001-08-09
KR20010111580A (ko) 2001-12-19
HUP0200995A2 (hu) 2002-07-29
IL145635A0 (en) 2002-06-30
EP1175414A1 (en) 2002-01-30
NO20014752D0 (no) 2001-10-01
NO20014752L (no) 2001-11-27
AU3481001A (en) 2001-08-14
HUP0200995A3 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AUPR213700A0 (en) Antiviral agents
MA27040A1 (fr) Nucleosides substitues en 4'
FR2805817B1 (fr) Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
BR9902086A (pt) Formulações farmacêuticas.
SE0001899D0 (sv) New compounds
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
BR0212386A (pt) Composto, formulação farmacêutica, e, uso de um composto
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
BR0211972A (pt) Composição oftálmica
DE60012988D1 (en) Taxane mit carbonaten in c-4
PT992509E (pt) Novos derivados macrolidos
BR0105563A (pt) Derivados e análogos de galantamina
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE60128100D1 (de) Analgetisches arzneimittel
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
MA27922A1 (fr) Formulations semi-solides de derives d'azetidine
BR0014687A (pt) Compostos de taxano pentacìclico
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.